The maker of pharmaceutical blockbuster Wegovy for expects shortages to be resolved in the next few months as it ramps up production.The obesity medicine has taken the country by storm since its approval in 2021 to treat obesity, a condition that is only recently being reconsidered as a result of myriad genetic and environmental factors outside of a person’s control.An explosion in demand combined with manufacturing hiccups caused a contraction in the last year, leaving behind a shortage of both Wegovy and its sister drug Ozempic.
Load More
Load More